GlobeNewsWire
02 Feb 2026, 13:35 UTC · 34w ago
Perspective Therapeutics Announces Pricing of $175 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Verdict
Headline takes no side. We score CATX +0.40 across four claims — moderately bullish.
- Expected · CATX
+0.40moderately bullish
−1 bearish0bullish +1More positive than 67% of ticker scores this week





